Clozapine-induced myocarditis is an overlooked adverse reaction with an estimated incidence of 3%, highlighting the need for monitoring procedures.
It is likely that the incidence of myocarditis is around 3%. Implementation of monitoring procedures will increase case ascertainment and result in more patients benefiting from this valuable medication.
Ronaldson et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: